Evofem Biosciences Announces Financial Results for the First Quarter of 2023

— Increased net product revenue 37% in the first quarter of 2023 vs. prior year quarter — — Reduced operating expenses 72% — — Decreased loss from operations by 88% — — Reaffirms path to positive EBITDA — SAN DIEGO, June 16, 2023 /PRNewswire/ — Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced financial results for … Read more

Evofem Biosciences Announces 1-for-125 Reverse Stock Split

—¬†CUSIP number for Evofem will change to 30048L302 on May 18, 2023 — — Ticker symbol will change to “EVFMD” for 20 business days, then revert to “EVFM” — SAN DIEGO, May 17, 2023 /PRNewswire/ — Evofem Biosciences, Inc., (OTCQB: EVFM) (the “Company”) today announced a 1-for-125 reverse stock split of the Company’s common stock, … Read more